1 link tagged with all of: healthcare + teva pharmaceuticals + interchangeability
Click any tag below to further narrow down your results
Links
This is a virtual panel discussion about removing barriers to biosimilar access and affordability. Speakers from Teva and a healthcare advisory firm will discuss how policy changes like interchangeability rules and better payer economics can make biosimilars easier for patients to get.
- Early biosimilar launches faced friction around access, pharmacy policies, and insurance coverage that complicated patient access
- Policy shifts like interchangeability designations and reformed health-plan economics are key to reducing friction in the biosimilar market
- Alignment between policy, supply reliability, and payer incentives is necessary to make biosimilars affordable and accessible
+ biosimilars
teva pharmaceuticals
+ omnihealthrx advisors
interchangeability
healthcare
+ market access